matchedPattern,context,lineNumber,columnNumber,publicationName
46G>A,"...4 and 5, respectively. The additional presence of 46G>A (Ala16Thr) was noted, whilst 189C>T that nor...",7,916,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"..., 771C>T and 829G>A). On screening other samples, 46G>A was absent, but two new O alleles were found...",7,1144,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...hereas a hitherto undescribed mutation in exon 2 (46G>A) was found in all five samples. As opposed t...,43,294,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"... as several weak A alleles) had the new mutation, 46G>A (Ala16Thr). Amongst all these samples one O1...",49,230,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...ce the new allele has a novel mutation in exon 2 (46G>A) and an unexpected lack of the O1v-specific ...,112,54,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...al interesting characteristics. The mutation, nt. 46G>A (Ala16Thr) in exon 2, has not been described...",126,87,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...he concerted effect of the mutations in exon 2 at 46G>A (Ala16Thr), exon 3 at 106G>T (Val36Phe), exo...",130,829,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...o novel changes, the most important one of which (46G>A) results in an amino acid substitution in th...",141,344,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...mplification-sequencing of intron 2 /screening of 46G>A,167,92,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...A-F	F4	CCAGGAAAACCAAAATGCCACA	exon 2	screening of 46G>A,168,57,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...gle-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one...",3,2002,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...ing of the receptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP binding ...",18,603,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...nor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while hav...",34,82,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...ll rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.17...",41,66,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower L...,43,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,... previously published P2RX7 SNPs revealed that c.946G>A (p.Arg307Gln) was significantly associated w...,44,70,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,...ange in LS-BMD did not differ significantly by c.946G>A genotype (âˆ’0.39%/year (SEM 0.06) for GG subj...,44,738,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...n association of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in pos...",52,81,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,...ding effects on bone loss or baseline BMD. The c.946G>A polymorphism changes arginine to glutamine a...,52,609,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
46G>A,"...meability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show complete...",52,982,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
